why is tirzepatide being taken off the market Compounded Market: What Are Your Weight Loss Options Now? Tirzepatide Statistics 2026: Mounjaro &

Strategic collaborations between biotech firms and digital health providers are further enhancing patient engagement and long-term outcomes

MOUNJARO (tirzepatide) Injection, for subcutaneous use

GLP-1 Drugs and Addiction Treatment: Signal, Hype, and What Comes Next The past two years have turned GLP-1 drugs into cultural icons

Weight loss telehealth in 2026 means navigating a patchwork of state licensing rules , deciding between cash-pay simplicity versus insurance administrative burden , understanding realistic patient acquisition costs (not the fantasy numbers some platforms advertise), and managing patient retention in a field where dropout rates are high